Welcome to our dedicated page for McKesson Corporation news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson Corporation stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
McKesson Corporation (NYSE: MCK) announced the election of W. Roy Dunbar as a new director and member of the Audit and Governance Committees, effective April 1, 2022. This expands the board from 11 to 12 members, with 11 being independent. Dunbar brings extensive experience from roles at Network Solutions, Mastercard, and Eli Lilly, focusing on technology, operations, and sustainability. His addition is expected to enhance the board's oversight, particularly in oncology, biopharma, data governance, and cybersecurity.
Settlement Announcement: AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have reached an agreement to settle the majority of opioid lawsuits with participation from 46 of 49 eligible states and over 90% of litigating political subdivisions. The settlement totals approximately $19.5 billion to be distributed over 18 years, with individual contributions of $6.1 billion, $6.0 billion, and $7.4 billion from AmerisourceBergen, Cardinal Health, and McKesson, respectively. The agreement aims to provide relief to communities affected by the opioid crisis.
McKesson Corporation (NYSE: MCK) announced its fiscal 2022 third-quarter financial results. Investors can access detailed results through the company's Investor Relations website. A live webcast of the earnings conference call will be held on February 2 at 4:30 PM ET, where management will discuss financial performance. McKesson has been recognized as a leading healthcare supply chain management provider and is noted for its commitment to patient health through innovative healthcare solutions.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 47 cents per share, set for payment on April 1, 2022, to stockholders of record on March 1, 2022. McKesson, a leader in healthcare supply chain management, emphasizes its commitment to providing essential healthcare services. Recognized as a top company in various categories, McKesson continues to enhance its reputation and investor confidence through consistent dividend payments.
McKesson Corporation (NYSE: MCK) announced the election of James H. Hinton and Kathleen Wilson-Thompson as new board directors on Jan. 13, 2022, increasing the board from 9 to 11 members. Hinton, an operating partner at Welsh, Carson, Anderson & Stone, previously served as CEO of Baylor Scott & White Health, while Wilson-Thompson was EVP and global chief human resources officer at Walgreens Boots Alliance. Their extensive healthcare leadership experience is expected to strengthen McKesson's governance and strategic direction.
McKesson Corporation (NYSE: MCK) will announce its third quarter fiscal 2022 financial results on February 2, 2022, after market close. A live webcast will follow at 4:30 PM ET to discuss the results. McKesson will also participate in the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022. Investors can access the webcast and related financial information on McKesson’s Investor Relations website.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have extended the deadline for political subdivisions to join the proposed opioid settlement from January 2, 2022, to January 26, 2022. New Mexico confirmed its participation, raising total states in the settlement to 43, covering all U.S. territories and Washington, D.C. The deadline to assess sufficient participation has also been moved from February 1, 2022, to February 25, 2022. The companies aim to expedite relief to affected communities and remain committed to addressing the opioid crisis.
McKesson Corporation (NYSE: MCK) has agreed to sell its Austrian operations to Quadrifolia Management GmbH. This deal includes McKesson Austria’s Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH, expected to close in fiscal 2022 following regulatory approvals. CEO Brian Tyler stated this aligns with McKesson's strategy to streamline its portfolio and exit the European market, following previous agreements in the UK, France, Italy, Ireland, Portugal, Belgium, and Slovenia.
McKesson Corporation (NYSE: MCK) is hosting an Investor Day at 1:00 p.m. ET today to outline its strategy for sustainable growth. The event will cover progress in healthcare services and reaffirm commitments to expanding oncology and biopharma services. McKesson increased its fiscal 2022 Adjusted Earnings per Diluted Share guidance to $22.35-$22.95, boosted by the U.S. government's COVID-19 vaccine program. Additionally, a $4.0 billion share repurchase program was announced, highlighting a focus on shareholder value.
McKesson Corporation (NYSE: MCK) is set to host an Investor Day on December 8, 2021, from 1:00 PM to 4:00 PM ET in New York City. The event will include presentations by the leadership team, a live Q&A with CEO Brian Tyler and CFO Britt Vitalone, and discussions on the company’s progress towards sustainable growth and long-term financial outlook.
A video webcast will be available live and archived on McKesson's Investor Relations website.
FAQ
What is the current stock price of McKesson Corporation (MCK)?
What is the market cap of McKesson Corporation (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
